BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 28460484)

  • 21. Therapeutic targeting of CBP/β-catenin signaling reduces cancer stem-like population and synergistically suppresses growth of EBV-positive nasopharyngeal carcinoma cells with cisplatin.
    Chan KC; Chan LS; Ip JC; Lo C; Yip TT; Ngan RK; Wong RN; Lo KW; Ng WT; Lee AW; Tsao GS; Kahn M; Lung ML; Mak NK
    Sci Rep; 2015 Apr; 5():9979. PubMed ID: 25897700
    [TBL] [Abstract][Full Text] [Related]  

  • 22. AURKA governs self-renewal capacity in glioma-initiating cells via stabilization/activation of β-catenin/Wnt signaling.
    Xia Z; Wei P; Zhang H; Ding Z; Yang L; Huang Z; Zhang N
    Mol Cancer Res; 2013 Sep; 11(9):1101-11. PubMed ID: 23761169
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RNA-binding motif protein 5 negatively regulates the activity of Wnt/β-catenin signaling in cigarette smoke-induced alveolar epithelial injury.
    Hao YQ; Su ZZ; Lv XJ; Li P; Gao P; Wang C; Bai Y; Zhang J
    Oncol Rep; 2015 May; 33(5):2438-44. PubMed ID: 25738917
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Canonical Wnt pathway inhibitor ICG-001 induces cytotoxicity of multiple myeloma cells in Wnt-independent manner.
    Grigson ER; Ozerova M; Pisklakova A; Liu H; Sullivan DM; Nefedova Y
    PLoS One; 2015; 10(1):e0117693. PubMed ID: 25635944
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diallyl trisulfide inhibits proliferation, invasion and angiogenesis of glioma cells by inactivating Wnt/β-catenin signaling.
    Tao Q; Wu C; Xu R; Niu L; Qin J; Liu N; Zhang P; Wang C
    Cell Tissue Res; 2017 Dec; 370(3):379-390. PubMed ID: 28815294
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PHF21B overexpression promotes cancer stem cell-like traits in prostate cancer cells by activating the Wnt/β-catenin signaling pathway.
    Li Q; Ye L; Guo W; Wang M; Huang S; Peng X
    J Exp Clin Cancer Res; 2017 Jun; 36(1):85. PubMed ID: 28645312
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chronic chemotherapeutic stress promotes evolution of stemness and WNT/beta-catenin signaling in colorectal cancer cells: implications for clinical use of WNT-signaling inhibitors.
    Ayadi M; Bouygues A; Ouaret D; Ferrand N; Chouaib S; Thiery JP; Muchardt C; Sabbah M; Larsen AK
    Oncotarget; 2015 Jul; 6(21):18518-33. PubMed ID: 26041882
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Deubiquitinase USP9X deubiquitinates β-catenin and promotes high grade glioma cell growth.
    Yang B; Zhang S; Wang Z; Yang C; Ouyang W; Zhou F; Zhou Y; Xie C
    Oncotarget; 2016 Nov; 7(48):79515-79525. PubMed ID: 27783990
    [TBL] [Abstract][Full Text] [Related]  

  • 29. BET degrader inhibits tumor progression and stem-like cell growth via Wnt/β-catenin signaling repression in glioma cells.
    Tian T; Guo T; Zhen W; Zou J; Li F
    Cell Death Dis; 2020 Oct; 11(10):900. PubMed ID: 33093476
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Downregulation of SCAI enhances glioma cell invasion and stem cell like phenotype by activating Wnt/β-catenin signaling.
    Chen X; Hu W; Xie B; Gao H; Xu C; Chen J
    Biochem Biophys Res Commun; 2014 May; 448(2):206-11. PubMed ID: 24785374
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Specific inhibition of CBP/beta-catenin interaction rescues defects in neuronal differentiation caused by a presenilin-1 mutation.
    Teo JL; Ma H; Nguyen C; Lam C; Kahn M
    Proc Natl Acad Sci U S A; 2005 Aug; 102(34):12171-6. PubMed ID: 16093313
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting Wnt signaling for improved glioma immunotherapy.
    Gutova M; Hibbard JC; Ma E; Natri HM; Adhikarla V; Chimge NO; Qiu R; Nguyen C; Melendez E; Aguilar B; Starr R; Yin H; Rockne RC; Ono M; Banovich NE; Yuan YC; Brown CE; Kahn M
    Front Immunol; 2024; 15():1342625. PubMed ID: 38449858
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification and characterization of a novel small-molecule inhibitor of β-catenin signaling.
    Delgado ER; Yang J; So J; Leimgruber S; Kahn M; Ishitani T; Shin D; Mustata Wilson G; Monga SP
    Am J Pathol; 2014 Jul; 184(7):2111-22. PubMed ID: 24819961
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Small molecule antagonists of the Wnt/β-catenin signaling pathway target breast tumor-initiating cells in a Her2/Neu mouse model of breast cancer.
    Hallett RM; Kondratyev MK; Giacomelli AO; Nixon AM; Girgis-Gabardo A; Ilieva D; Hassell JA
    PLoS One; 2012; 7(3):e33976. PubMed ID: 22470504
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ATF4 promotes lung cancer cell proliferation and invasion partially through regulating Wnt/β-catenin signaling.
    Du J; Liu H; Mao X; Qin Y; Fan C
    Int J Med Sci; 2021; 18(6):1442-1448. PubMed ID: 33628101
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sam68 Allows Selective Targeting of Human Cancer Stem Cells.
    Benoit YD; Mitchell RR; Risueño RM; Orlando L; Tanasijevic B; Boyd AL; Aslostovar L; Salci KR; Shapovalova Z; Russell J; Eguchi M; Golubeva D; Graham M; Xenocostas A; Trus MR; Foley R; Leber B; Collins TJ; Bhatia M
    Cell Chem Biol; 2017 Jul; 24(7):833-844.e9. PubMed ID: 28648376
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The novel inhibitor PRI-724 for Wnt/β-catenin/CBP signaling ameliorates bleomycin-induced pulmonary fibrosis in mice.
    Okazaki H; Sato S; Koyama K; Morizumi S; Abe S; Azuma M; Chen Y; Goto H; Aono Y; Ogawa H; Kagawa K; Nishimura H; Kawano H; Toyoda Y; Uehara H; Kouji H; Nishioka Y
    Exp Lung Res; 2019 Sep; 45(7):188-199. PubMed ID: 31298961
    [No Abstract]   [Full Text] [Related]  

  • 38. Inhibition of Wnt/β-catenin signaling suppresses myofibroblast differentiation of lung resident mesenchymal stem cells and pulmonary fibrosis.
    Cao H; Wang C; Chen X; Hou J; Xiang Z; Shen Y; Han X
    Sci Rep; 2018 Sep; 8(1):13644. PubMed ID: 30206265
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of Wnt/beta-catenin/CREB binding protein (CBP) signaling reverses pulmonary fibrosis.
    Henderson WR; Chi EY; Ye X; Nguyen C; Tien YT; Zhou B; Borok Z; Knight DA; Kahn M
    Proc Natl Acad Sci U S A; 2010 Aug; 107(32):14309-14. PubMed ID: 20660310
    [TBL] [Abstract][Full Text] [Related]  

  • 40. R132H mutation in IDH1 gene reduces proliferation, cell survival and invasion of human glioma by downregulating Wnt/β-catenin signaling.
    Cui D; Ren J; Shi J; Feng L; Wang K; Zeng T; Jin Y; Gao L
    Int J Biochem Cell Biol; 2016 Apr; 73():72-81. PubMed ID: 26860959
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.